Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: Changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates

Pediatric Infectious Disease Journal

Volumn 23, Issue 11, 2004, Pages 1015-1022

  Pelton, Stephen I ^a   Loughlin, Anita M ^a   Marchant, Colin D ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic resistance; Nasopharyngeal carriage; Pneumococcal conjugate vaccine; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; COTRIMOXAZOLE; PENICILLIN G; PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; MENINGOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFECT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MASS IMMUNIZATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EVOLUTION; NONHUMAN; OTITIS MEDIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HETEROZYGOTE; ISOLATION AND PURIFICATION; MALE; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NASOPHARYNX; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS INFECTION; URBAN POPULATION; VACCINATION;

ANTI-BACTERIAL AGENTS; BOSTON; CARRIER STATE; CHILD, PRESCHOOL; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; MALE; MENINGOCOCCAL VACCINES; MICROBIAL SENSITIVITY TESTS; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS PNEUMONIAE; URBAN POPULATION; VACCINATION;

EID: 16544395629     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000143645.58215.f0     Document Type: Article

References (26)

1. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000;19:187-195.
2. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403-409.
3. Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Diagn Microbiol Infect Dis. 2003;22:10-16.
4. Black SB, Shinefield HR, Ling S, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J. 2002;21:810-815.
5. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-1746.
6. Kaplan SL, Mason EO, Wald ER, et al. Decrease of immune pneumococcal infection in children among eight children's hospitals in the United States following introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004;113(3 pt 1):443-449.
7. Dagan R, Givon-Lavi N, Zamir O, et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine in toddlers attending day care centers. J Infect Dis. 2002;185:927-936.
8. Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, Klugman KP. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis. 1999;180:1171-1176.
9. Dagan R, Melamed R, Muallem M, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis. 1996;174:1271-1278.
10. Dagan R, Sikuler-Cohen M, Zamir O, Janco J, Givon-Lavi N, Fraser D. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infection and antibiotic use in day-care center attendees. Pediatr Infect Dis J. 2001;20:951-958.
11. Joloba ML, Windau A, Bajaksouzian S, Applebaum PC, Hausdorff WP, Jacobs MR. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media. Clin Infect Dis. 2001;33:1489-1494.
12. Wust J, Huf E, Kayser FH. Antimicrobial susceptibilities and serotypes of invasive Streptococcus pneumoniae stains in Switzerland. J Clin Microbiol. 1995;33:3159-3163.
13. Dagan R, Givon-Alvi N, Zamir O, Fraser D. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr Infect Dis J. 2003;22:532-540.
14. Jacobs MR, Bajaksouzian S, Zilles A, Lin G, Pankuch G, Appelbaum PC. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance Study. Antimicrob Agents Chemother. 1999;43:1901-1908.
15. Craig WA, Andes D. Pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J. 1996;15:255-259.
16. Leiberman A, Leibovitz E, Piglansky L, et al. Bacteriologic and clinical efficay of trimethoprim-sulfamethoxazole for treatment of acute otits media. Pediatr Infect Dis J. 2001;20:260-264.
17. Dagan R, Johnson CE, McLinn S, et al. Bacteriologic and clinical efficay of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J. 2000;19:95-104.
18. Jacobs MR. Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters. Pediatr Infect Dis J. 2000;19:S47-S55.
19. Deleted in proof.
20. www2a.cdc.gov/nip/default.htm.
21. Ghaffar F, Barton T, Lozano J, et al. Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first two years of life. In: 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September September 14-17, 2003; Chicago, IL. Abstract. Washington, DC: American Society for Microbiology, 2003.
22. Givon-Lavi N, Fraser D, Dagan R. Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings. Pediatr Infect Dis J. 2003;22:524-532.
23. Klugman KP. Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. Lancet Infect Dis. 2001; 1:85-91.
24. Nurkka A, Ahman H, Yaich M, Eskola J, Kayhty H. Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT. Vaccine. 2001; 20:194-201.
25. Choo S, Zhang Q, Seymour L, Akhtar S, Finn A. Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants. J Infect Dis. 2000;182:1260-1263.
26. McEllistrem MC, Adams J, Mason EO, Wald ER. Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J Infect Dis. 2003;188:1679-1684.